|
|
Article: New treatment targets seasonal ocular allergic conjunctivitis
- Article from:
- Ophthalmology Times
- Article date:
- August 15, 2004
- Author:
CopyrightCopyright Advanstar Communications, Inc. Aug 15, 2004. Provided by ProQuest LLC. (Hide copyright information)
|
European trial
New treatment targets seasonal ocular allergic conjunctivitis
Mast cell stabilizer offers symptomatic relief with reduction in itching, hyperemia, lid swelling, tearing
Reviewed by Stefano Bonini, MD
Fort Lauderdale, FL-Ophthalmic epinastine HCl is a new therapy for symptomatic relief of seasonal allergic conjunctivitis that is at least as effective and well tolerated as ketotifen fumarate (Zaditor, Novartis Pharmaceuticals, Duluth, GA), reported Stefano Bonini, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
The results of the European Epinastine Study Group showed that compared with ketotifen, the drug provided clinical improvements ...